University of California- Los Angeles (UCLA)

Los Angeles, California 990095

29 studies enrolling now · 110 studies all time

What they study most

AVB - Atrioventricular Block, Acute Ischemic Stroke, Acute Myeloid Leukemia, Adamantinomatous Craniopharyngioma, Adenoid Cystic Carcinoma, Adenosine Deaminase Severe Combined Immune Deficiency, Adenovirus Infection, Adenylosuccinate Synthase 1 Deficient Myopathy, Adolescent Behavior, Advanced Cancer, Advanced Gastrointestinal Stromal Tumors, Advanced Solid Tumor

Studies at this site

• A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections — Recruiting now
• A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy — Recruiting now
• A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer — Recruiting now
• A Study of 177Lu-FAP-2286 in Advanced Solid Tumors — Recruiting now
• FOG-001 in Locally Advanced or Metastatic Solid Tumors — Recruiting now
• A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer — Recruiting now
• A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care — Recruiting now
• (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors — Recruiting now
• Evaluating tDCS Brain-stimulation in Depression Using MRI — Recruiting now
• Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging. — Recruiting now
• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) — Recruiting now
• A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment — Recruiting now
• Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID — Recruiting now
• Platform of Randomized Adaptive Clinical Trials in Critical Illness — Recruiting now
• Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke — Recruiting now
• A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM). — Recruiting now
• Gene Therapy for Adenosine Deaminase Severe Combined Immune Deficiency Using Peripheral Blood and EFS ADA Vector — Recruiting now
• Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ) — Recruiting now
• A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma — Recruiting now
• Secretin in Refeeding — Recruiting now
• Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants — Recruiting now
• Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy — Recruiting now
• Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems — Recruiting now
• Safety and Efficacy Study of GEB-101 Injection in Subjects With TGFBI-related Corneal Dystrophy — Starting soon
• A Study to Evaluate the Efficacy and Safety of Rivoceranib in Participants With Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC) — Stopped early
• Long-term Extension of GTX-102 in Angelman Syndrome — Enrolling by invitation
• Global Open-Label Extension Study of Del-desiran for the Treatment of DM1 — Enrolling by invitation
• Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer — Running, not enrolling
• MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas — Running, not enrolling
• INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study — Starting soon
• A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have — Running, not enrolling
• The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY) — Running, not enrolling
• Suzetrigine for Opioid-Sparing Postoperative Analgesia Following Transvaginal Pelvic Reconstructive Surgery — Starting soon
• Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE) — Completed
• Assisted Fluid Management (AFM) System and Postoperative Outcome After High-risk Abdominal Surgery — Completed
• Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS) — Stopped early
• A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment — Completed
• Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma — Running, not enrolling
• A Phase 1b Study of Adenylosuccinic Acid (ASA-001) for Adenylosuccinate Synthase 1 (ADSS1) Deficient Myopathy. — Enrolling by invitation
• Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple Myeloma — Available (expanded access)
• Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease — Starting soon
• Long-Term Follow-Up (LTFU) for Gene Therapy of Leukocyte Adhesion Deficiency-I (LAD-I) — Running, not enrolling
• Stem Cell Gene Therapy for Sickle Cell Disease — Completed
• Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH) — Stopped early
• Study of ART0380 in Patients With Biologically Selected Solid Tumors — Stopped early
• Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib. — Running, not enrolling
• A Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome — Stopped early
• Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy — Completed
• Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial — Completed
• Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE) — Stopped early